Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The renal tubular cell apoptosis pathway encompasses the molecular signaling events leading to programmed cell death in renal tubular epithelial cells, especially under pathologic conditions such as ischemia, sepsis, oxidative stress, and exposure to nephrotoxic agents[1][2][3]. Apoptosis is initiated through intrinsic (mitochondrial; regulated by Bcl-2 family proteins such as Bax and Bak) and extrinsic (death receptor-mediated, including Fas/CD95 and TNF receptor superfamily) mechanisms, converging on effector caspases like caspase-3[1][3]. Key upstream stimuli include oxidative stress, endoplasmic reticulum (ER) stress (involving the PERK-eIF2α-ATF4-CHOP axis), and activation of stress kinases such as JNK and p38 MAPK[4][5]. Excessive apoptosis contributes to the loss of renal tubular cells, progression of acute kidney injury, tubulointerstitial fibrosis, and chronic kidney disease, whereas therapeutic modulation—via agents targeting pathway intermediates—can promote renal recovery and mitigate disease progression[1][2][4][5][6]. The pathway itself is not a singular drug target, but several of its molecular components (e.g., SIRT1, HRD1, JNK/p38, caspases, Bcl-2 family proteins) are studied as potential targets for intervention[1][2][3][4][5][6].
Inhibition of apoptosis signaling cascades (e.g., blocking caspases, Bcl-2 family modulation)[1][3][4][5][6] Reduction of oxidative stress[5][6] Modulation of ER stress and PERK-eIF2α-ATF4-CHOP pathway[4] SIRT1 activation for anti-apoptotic and anti-inflammatory effects[6] Inhibition of stress kinases (JNK/p38)[5]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal tubular cell apoptosis pathway.